BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 9021998)

  • 1. Co-receptor-independent signal transduction in a mismatched CD8+ major histocompatibility complex class II-specific allogeneic cytotoxic T lymphocyte.
    Eshima K; Tachibana M; Suzuki H; Yamazaki S; Shinohara N
    Eur J Immunol; 1997 Jan; 27(1):55-61. PubMed ID: 9021998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
    Lustgarten J; Waks T; Eshhar Z
    Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CD4 can confer major histocompatibility complex class II-associated superantigen reactivity upon a T cell receptor derived from a CD8-dependent cytotoxic T lymphocyte clone.
    Wallace VA; Ohashi PS; Hengartner H; Mak TW
    Eur J Immunol; 1990 Nov; 20(11):2471-7. PubMed ID: 2123792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced T cell maturation and altered lineage commitment in T cell receptor/CD4-transgenic mice.
    Lieberman SA; Spain LM; Wang L; Berg LJ
    Cell Immunol; 1995 Apr; 162(1):56-67. PubMed ID: 7704911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8 inhibits signal transduction through the T cell receptor in CD4-CD8- thymocytes from T cell receptor transgenic mice reconstituted with a transgenic CD8 alpha molecule.
    van Oers NS; Teh SJ; Garvin AM; Forbush KA; Perlmutter RM; Teh HS
    J Immunol; 1993 Jul; 151(2):777-90. PubMed ID: 8335907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell receptor and CD8-dependent tyrosine phosphorylation events in cytotoxic T lymphocytes: activation of p56lck by CD8 binding to class I protein.
    Anel A; O'Rourke AM; Kleinfeld AM; Mescher MF
    Eur J Immunol; 1996 Oct; 26(10):2310-9. PubMed ID: 8898939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The duration of antigen receptor signalling determines CD4+ versus CD8+ T-cell lineage fate.
    Yasutomo K; Doyle C; Miele L; Fuchs C; Germain RN
    Nature; 2000 Mar; 404(6777):506-10. PubMed ID: 10761920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymic development in human CD4 transgenic mice. Positive selection occurs after commitment to the CD8 lineage.
    Paterson RK; Burkly LC; Kurahara DK; Dunlap A; Flavell RA; Finkel TH
    J Immunol; 1994 Oct; 153(8):3491-503. PubMed ID: 7930572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class I- and class II-reactive TCRs coexpressed on CD4+ T cells both trigger CD4/CD8-shared and CD4-unique functions.
    Asnagli H; Schmitt-Verhulst AM; Guimezanes A
    J Immunol; 1997 May; 158(10):4533-42. PubMed ID: 9144464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumors.
    Marzo AL; Lake RA; Robinson BW; Scott B
    Cancer Res; 1999 Mar; 59(5):1071-9. PubMed ID: 10070965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4 function in thymocyte differentiation and T cell activation.
    Killeen N; Davis CB; Chu K; Crooks ME; Sawada S; Scarborough JD; Boyd KA; Stuart SG; Xu H; Littman DR
    Philos Trans R Soc Lond B Biol Sci; 1993 Oct; 342(1299):25-34. PubMed ID: 7904343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The degree of CD8 dependence of cytolytic T cell precursors is determined by the nature of the T cell receptor (TCR) and influences negative selection in TCR-transgenic mice.
    Auphan N; Curnow J; Guimezanes A; Langlet C; Malissen B; Mellor A; Schmitt-Verhulst AM
    Eur J Immunol; 1994 Jul; 24(7):1572-7. PubMed ID: 8026519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal for T-cell differentiation to a CD4 cell lineage is delivered by CD4 transmembrane region and/or cytoplasmic tail.
    Seong RH; Chamberlain JW; Parnes JR
    Nature; 1992 Apr; 356(6371):718-20. PubMed ID: 1533274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Existence of mature human CD4+ T cells with genuine class I restriction.
    De Bueger M; Bakker A; Goulmy E
    Eur J Immunol; 1992 Mar; 22(3):875-8. PubMed ID: 1372262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signals through CD8 or CD4 can induce commitment to the CD4 lineage in the thymus.
    Bommhardt U; Cole MS; Tso JY; Zamoyska R
    Eur J Immunol; 1997 May; 27(5):1152-63. PubMed ID: 9174605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha beta T cell receptor-positive intraepithelial lymphocytes with CD4+, CD8- and CD4+, CD8+ phenotypes from orally immunized mice provide Th2-like function for B cell responses.
    Fujihashi K; Yamamoto M; McGhee JR; Kiyono H
    J Immunol; 1993 Dec; 151(12):6681-91. PubMed ID: 7903096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of phosphorylation and internalization of the antigen receptor/CD3 complex, CD8, and class I MHC-encoded proteins on T cells. Role of intracytoplasmic domains analyzed with hybrid CD8/class I molecules.
    Boyer C; Auphan N; Gabert J; Blanc D; Malissen B; Schmitt-Verhulst AM
    J Immunol; 1989 Sep; 143(6):1905-14. PubMed ID: 2506271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of MHC class I-restricted CD8+ CTL by microbial T cell mitogens. Dependence upon MHC class II expression of the target cells and V beta usage of the responder T cells.
    Herrmann T; Maryanski JL; Romero P; Fleischer B; MacDonald HR
    J Immunol; 1990 Feb; 144(4):1181-6. PubMed ID: 1968075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro.
    Muraoka S
    Eur J Immunol; 1991 Sep; 21(9):2095-103. PubMed ID: 1679712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles of CD4 and CD8 in T cell activation.
    Miceli MC; Parnes JR
    Semin Immunol; 1991 May; 3(3):133-41. PubMed ID: 1909592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.